BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 15461548)

  • 1. Tacrolimus ointment: the treatment of atopic dermatitis and other inflammatory cutaneous disease.
    Carroll CL; Fleischer AB
    Expert Opin Pharmacother; 2004 Oct; 5(10):2127-37. PubMed ID: 15461548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus ointment (Protopic) for atopic dermatitis.
    Pascual JC; Fleisher AB
    Skin Therapy Lett; 2004 Nov; 9(9):1-5. PubMed ID: 15550992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus clinical studies for atopic dermatitis and other conditions.
    Bergman J; Rico MJ
    Semin Cutan Med Surg; 2001 Dec; 20(4):250-9. PubMed ID: 11770912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An approach to pruritus in atopic dermatitis: a critical systematic review of the tacrolimus ointment literature.
    Fleischer AB; Boguniewicz M
    J Drugs Dermatol; 2010 May; 9(5):488-98. PubMed ID: 20480792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions.
    Simpson D; Noble S
    Drugs; 2005; 65(6):827-58. PubMed ID: 15819596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis.
    Nghiem P; Pearson G; Langley RG
    J Am Acad Dermatol; 2002 Feb; 46(2):228-41. PubMed ID: 11807435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
    Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
    J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
    Bornhövd E; Burgdorf WH; Wollenberg A
    J Am Acad Dermatol; 2001 Nov; 45(5):736-43. PubMed ID: 11606925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety of tacrolimus ointment in children treated for atopic dermatitis.
    Shainhouse T; Eichenfield LF
    Expert Opin Drug Saf; 2003 Sep; 2(5):457-65. PubMed ID: 12946246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
    Hultsch T; Kapp A; Spergel J
    Dermatology; 2005; 211(2):174-87. PubMed ID: 16088174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter trial of the efficacy and safety of 0.03% tacrolimus ointment for atopic dermatitis in Korea.
    Won CH; Seo PG; Park YM; Yang JM; Lee KH; Sung KJ; Park CW; Kim DW; Chang HS; Won YH; Kim KH
    J Dermatolog Treat; 2004 Jan; 15(1):30-4. PubMed ID: 14754647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical tacrolimus and pimecrolimus: future directions.
    Ling MR
    Semin Cutan Med Surg; 2001 Dec; 20(4):268-74. PubMed ID: 11770914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus pharmacology and nonclinical studies: from FK506 to protopic.
    Bekersky I; Lilja H; Lawrence I
    Semin Cutan Med Surg; 2001 Dec; 20(4):226-32. PubMed ID: 11770909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New immune suppressants: topical immunomodulatory agents].
    Senatorski G; Sułowicz W; Paczek L
    Przegl Lek; 2002; 59(11):907-11. PubMed ID: 12715720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids.
    Kirsner RS; Heffernan MP; Antaya R
    Acta Derm Venereol; 2010; 90(1):58-64. PubMed ID: 20107727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical tacrolimus in adult atopic dermatitis: a consensus based on a 15-year experience.
    Calzavara-Pinton P; Fabbrocini G; Girolomoni G; Matiucci A; Micali G; Musumeci ML; Patruno C; Pellacani G; Rossi MT; Castello M; Stingeni L
    G Ital Dermatol Venereol; 2020 Feb; 155(1):8-13. PubMed ID: 31760730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety of tacrolimus ointment in atopic dermatitis.
    Remitz A; Reitamo S
    Expert Opin Drug Saf; 2009 Jul; 8(4):501-6. PubMed ID: 19435404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The treatment of atopic dermatitis in adults with topical calcineurin inhibitors].
    Meurer M; Wozel G
    Hautarzt; 2003 May; 54(5):424-31. PubMed ID: 12719862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.